AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

AAA Biotech enhances its recombinant proteins portfolio, offering high-quality research reagents to support groundbreaking biomedical research.

August 12, 2025
AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

AAA Biotech has announced significant additions to its recombinant proteins (rProteins) portfolio, reinforcing its position as a global leader in high-quality research reagents for the life sciences sector. This expansion is set to provide researchers with an even broader range of tools to explore complex biological targets and applications in their experiments.

Recombinant proteins are pivotal in modern life sciences research, serving as essential tools created through specific, controlled genetic engineering methods. These proteins are expressed in various active systems, including E. coli, mammalian cells like HEK293 and CHO, yeast, and insect cells, catering to a wide array of research needs. AAA Biotech ensures that each recombinant protein product meets stringent quality controls, with purities typically exceeding 95%, validated through affinity chromatography procedures. The proteins are available in multiple tagged formats, such as His, GST, FLAG, and Fc fusion, facilitating simple purification and detection processes.

The rProteins offered by AAA Biotech boast several standout features, including high purity and activity, with the majority guaranteed to be 95% pure and bioactivity forms specifically tested. The flexibility in expression systems allows for proteins to be produced in prokaryotic (E. coli) and eukaryotic (HEK293, CHO, yeast, insect) systems, accommodating folding, post-translational modification, and functionality requirements. These proteins are ideally suited for examining protein-protein and protein-DNA interactions, conducting functional biological assays, establishing standard ELISA curves, and aiding in drug discovery, including biomarker validation and immune signaling analysis.

Moreover, AAA Biotech provides options for custom expressions and tags to meet specific experimental needs, alongside rigorous quality control and documentation. Selected products undergo testing and analysis via SDS-PAGE, endotoxin, and, where applicable, activity assays, with Certificates of Analysis provided on a per-batch basis. The proteins are available in user-friendly lyophilized or ready-to-use liquid forms, simplifying storage and handling for researchers.

For further details on AAA Biotech's comprehensive range of research reagents, including validated antibodies and ELISA kits, visit their official website at https://www.aaabiotech.com/.